Antonello B.
- Country
- Italy
- Department
- Unit of Psychiatry
Research Overview
Data & Insights
Has run more than one trial at 0 of 3 partner sites.
Specializations
Metabolic Liver Disease
The investigator concentrates on Non-Alcoholic Steatohepatitis (NASH) and its related metabolic dysfunctions, including fibrosis progression and cirrhosis.
- NASH with fibrosis
- Metabolic Dysfunction-Associated Steatohepatitis (MASH)
- Compensated cirrhosis due to NASH
Research integrates metabolic risk factors such as obesity and type 2 diabetes.
Oncology
Key interests include advanced solid tumours, particularly prostate cancer and gastrointestinal malignancies.
- Metastatic castration‑resistant prostate cancer (mCRPC)
- Colorectal cancer (CRC)
- Pancreatic ductal adenocarcinoma (PDAC)
- Advanced biliary tract cancers
Efforts target therapeutic strategies for disease progression and metastasis.
Respiratory Fibrotic Disorders
The investigator is active in the study of progressive lung fibrosis, including idiopathic pulmonary fibrosis (IPF) and related interstitial lung diseases.
- Progressive fibrosing interstitial lung diseases (PF‑ILDs)
- Idiopathic pulmonary fibrosis (IPF)
- Interstitial lung disease‑associated pulmonary hypertension
Focus is on slowing functional decline and improving lung capacity.
Cardiovascular and Renal Medicine
Research spans heart failure phenotypes and chronic kidney disease, emphasizing heart failure with preserved ejection fraction (HFpEF).
- Heart failure (HF) and HFpEF
- Chronic kidney disease (CKD) with proteinuria
- Atrial fibrillation and stroke prevention
- Hypertension in CKD
Therapeutic evaluation includes novel combination regimens to reduce cardiovascular events.
Neurology and Psychiatry
In the psychiatric domain, the investigator addresses neurodegenerative and developmental conditions such as Alzheimer’s disease and autism.
- Alzheimer’s disease (mild to moderate)
- Multiple sclerosis (relapsing and progressive forms)
- Autism spectrum disorder (ASD)
- Treatment‑resistant depression (TRD)
Efforts aim to improve cognitive outcomes and symptom control.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.